Report Detail

Request for Sample of this report

Pharma & Healthcare Global Tuberculosis Vaccine Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4743929
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Tuberculosis Vaccine Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Tuberculosis Vaccine Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tuberculosis Vaccine Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Tuberculosis Vaccine Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Tuberculosis Vaccine Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Tuberculosis Vaccine Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis Vaccine Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis Vaccine Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tuberculosis Vaccine Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune Vaccine
Therapy Vaccine
Market segment by Application
Self-Procurement
UNICEF
Other
Major players covered
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccine Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccine Drug, with price, sales quantity, revenue, and global market share of Tuberculosis Vaccine Drug from 2021 to 2026.
Chapter 3, the Tuberculosis Vaccine Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccine Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tuberculosis Vaccine Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccine Drug.
Chapter 14 and 15, to describe Tuberculosis Vaccine Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tuberculosis Vaccine Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Immune Vaccine
    • 1.3.3 Therapy Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tuberculosis Vaccine Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Self-Procurement
    • 1.4.3 UNICEF
    • 1.4.4 Other
  • 1.5 Global Tuberculosis Vaccine Drug Market Size & Forecast
    • 1.5.1 Global Tuberculosis Vaccine Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Tuberculosis Vaccine Drug Sales Quantity (2021-2032)
    • 1.5.3 Global Tuberculosis Vaccine Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Tuberculosis Vaccine Drug Product and Services
    • 2.1.4 Merck Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Japan BCG Lab
    • 2.2.1 Japan BCG Lab Details
    • 2.2.2 Japan BCG Lab Major Business
    • 2.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Product and Services
    • 2.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Japan BCG Lab Recent Developments/Updates
  • 2.3 Serum Institute of India
    • 2.3.1 Serum Institute of India Details
    • 2.3.2 Serum Institute of India Major Business
    • 2.3.3 Serum Institute of India Tuberculosis Vaccine Drug Product and Services
    • 2.3.4 Serum Institute of India Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Serum Institute of India Recent Developments/Updates
  • 2.4 AJ Vaccines
    • 2.4.1 AJ Vaccines Details
    • 2.4.2 AJ Vaccines Major Business
    • 2.4.3 AJ Vaccines Tuberculosis Vaccine Drug Product and Services
    • 2.4.4 AJ Vaccines Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 AJ Vaccines Recent Developments/Updates
  • 2.5 BioFarma
    • 2.5.1 BioFarma Details
    • 2.5.2 BioFarma Major Business
    • 2.5.3 BioFarma Tuberculosis Vaccine Drug Product and Services
    • 2.5.4 BioFarma Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BioFarma Recent Developments/Updates
  • 2.6 GreenSignal Bio Pharma
    • 2.6.1 GreenSignal Bio Pharma Details
    • 2.6.2 GreenSignal Bio Pharma Major Business
    • 2.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product and Services
    • 2.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GreenSignal Bio Pharma Recent Developments/Updates
  • 2.7 China National Biotec
    • 2.7.1 China National Biotec Details
    • 2.7.2 China National Biotec Major Business
    • 2.7.3 China National Biotec Tuberculosis Vaccine Drug Product and Services
    • 2.7.4 China National Biotec Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 China National Biotec Recent Developments/Updates
  • 2.8 Biomed Lublin
    • 2.8.1 Biomed Lublin Details
    • 2.8.2 Biomed Lublin Major Business
    • 2.8.3 Biomed Lublin Tuberculosis Vaccine Drug Product and Services
    • 2.8.4 Biomed Lublin Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biomed Lublin Recent Developments/Updates
  • 2.9 Taj Pharmaceuticals
    • 2.9.1 Taj Pharmaceuticals Details
    • 2.9.2 Taj Pharmaceuticals Major Business
    • 2.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product and Services
    • 2.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Taj Pharmaceuticals Recent Developments/Updates
  • 2.10 Ataulpho de Paiva
    • 2.10.1 Ataulpho de Paiva Details
    • 2.10.2 Ataulpho de Paiva Major Business
    • 2.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Product and Services
    • 2.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ataulpho de Paiva Recent Developments/Updates
  • 2.11 IVAC
    • 2.11.1 IVAC Details
    • 2.11.2 IVAC Major Business
    • 2.11.3 IVAC Tuberculosis Vaccine Drug Product and Services
    • 2.11.4 IVAC Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 IVAC Recent Developments/Updates
  • 2.12 Queen Saovabha Mem. Inst
    • 2.12.1 Queen Saovabha Mem. Inst Details
    • 2.12.2 Queen Saovabha Mem. Inst Major Business
    • 2.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product and Services
    • 2.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
  • 2.13 Microgen
    • 2.13.1 Microgen Details
    • 2.13.2 Microgen Major Business
    • 2.13.3 Microgen Tuberculosis Vaccine Drug Product and Services
    • 2.13.4 Microgen Tuberculosis Vaccine Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Microgen Recent Developments/Updates

3 Competitive Environment: Tuberculosis Vaccine Drug by Manufacturer

  • 3.1 Global Tuberculosis Vaccine Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Tuberculosis Vaccine Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global Tuberculosis Vaccine Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Tuberculosis Vaccine Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Tuberculosis Vaccine Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Tuberculosis Vaccine Drug Manufacturer Market Share in 2025
  • 3.5 Tuberculosis Vaccine Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Tuberculosis Vaccine Drug Market: Region Footprint
    • 3.5.2 Tuberculosis Vaccine Drug Market: Company Product Type Footprint
    • 3.5.3 Tuberculosis Vaccine Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tuberculosis Vaccine Drug Market Size by Region
    • 4.1.1 Global Tuberculosis Vaccine Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Tuberculosis Vaccine Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global Tuberculosis Vaccine Drug Average Price by Region (2021-2032)
  • 4.2 North America Tuberculosis Vaccine Drug Consumption Value (2021-2032)
  • 4.3 Europe Tuberculosis Vaccine Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Tuberculosis Vaccine Drug Consumption Value (2021-2032)
  • 4.5 South America Tuberculosis Vaccine Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Tuberculosis Vaccine Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Tuberculosis Vaccine Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global Tuberculosis Vaccine Drug Consumption Value by Type (2021-2032)
  • 5.3 Global Tuberculosis Vaccine Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Tuberculosis Vaccine Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global Tuberculosis Vaccine Drug Consumption Value by Application (2021-2032)
  • 6.3 Global Tuberculosis Vaccine Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Tuberculosis Vaccine Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America Tuberculosis Vaccine Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America Tuberculosis Vaccine Drug Market Size by Country
    • 7.3.1 North America Tuberculosis Vaccine Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Tuberculosis Vaccine Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Tuberculosis Vaccine Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe Tuberculosis Vaccine Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe Tuberculosis Vaccine Drug Market Size by Country
    • 8.3.1 Europe Tuberculosis Vaccine Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Tuberculosis Vaccine Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tuberculosis Vaccine Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Tuberculosis Vaccine Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Tuberculosis Vaccine Drug Market Size by Region
    • 9.3.1 Asia-Pacific Tuberculosis Vaccine Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Tuberculosis Vaccine Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Tuberculosis Vaccine Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America Tuberculosis Vaccine Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America Tuberculosis Vaccine Drug Market Size by Country
    • 10.3.1 South America Tuberculosis Vaccine Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Tuberculosis Vaccine Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tuberculosis Vaccine Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Tuberculosis Vaccine Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Tuberculosis Vaccine Drug Market Size by Country
    • 11.3.1 Middle East & Africa Tuberculosis Vaccine Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Tuberculosis Vaccine Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Tuberculosis Vaccine Drug Market Drivers
  • 12.2 Tuberculosis Vaccine Drug Market Restraints
  • 12.3 Tuberculosis Vaccine Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tuberculosis Vaccine Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tuberculosis Vaccine Drug
  • 13.3 Tuberculosis Vaccine Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tuberculosis Vaccine Drug Typical Distributors
  • 14.3 Tuberculosis Vaccine Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Tuberculosis Vaccine Drug. Industry analysis & Market Report on Tuberculosis Vaccine Drug is a syndicated market report, published as Global Tuberculosis Vaccine Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Tuberculosis Vaccine Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo